Fiskus, W., Mill, C., Masarova, L., Pemmaraju, N., Bose, P., Gupta, A., Hou, H., Manshouri, T., Senapati, J., Loghavi, S., Dunbar, A., Wahlestedt, C., DiNardo, C., Bhalla, K. (2025). Preclinical efficacy of dual BET/HAT inhibitor–based combinations against post myeloproliferative neoplasm secondary AML cells. Blood. https://doi.org/10.1182/blood-2025-5053